-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Adient, Raises Price Target to $15

Benzinga·05/08/2025 18:40:45
Listen to the news
UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Neutral and raises the price target from $13 to $15.